FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

19525211000001103: Linagliptin 5mg tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Oct 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
66075501000001116 Linagliptin 5mg tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
66075601000001117 Linagliptin 5mg tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

4 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Linagliptin 5mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tablet.oral ontology form and route true Inferred relationship Existential restriction modifier
Linagliptin 5mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Linagliptin 5mg tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Linagliptin 5mg tablets Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Linagliptin 5mg tablets Is a Linagliptin true Inferred relationship Existential restriction modifier
Linagliptin 5mg tablets Is a Linagliptin false Inferred relationship Existential restriction modifier
Linagliptin 5mg tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Linagliptin 5mg tablets Has specific active ingredient Linagliptin false Inferred relationship Existential restriction modifier
Linagliptin 5mg tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Linagliptin 5mg tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Linagliptin 5mg tablets Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Linagliptin 5mg tablets Has specific active ingredient Linagliptin true Inferred relationship Existential restriction modifier
Linagliptin 5mg tablets Is a Product containing linagliptin false Inferred relationship Existential restriction modifier
Linagliptin 5mg tablets Has active ingredient Linagliptin false Inferred relationship Existential restriction modifier
Linagliptin 5mg tablets Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Trajenta 5mg tablets (CST Pharma Ltd) Is a True Linagliptin 5mg tablets Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (DE Pharmaceuticals) Is a True Linagliptin 5mg tablets Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (Boehringer Ingelheim Ltd) Is a True Linagliptin 5mg tablets Inferred relationship Existential restriction modifier
Linagliptin 5mg tablets 28 tablet Has VMP True Linagliptin 5mg tablets Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (Pharmaram Ltd) Is a True Linagliptin 5mg tablets Inferred relationship Existential restriction modifier
Linagliptin 5mg tablets 30 tablet Has VMP True Linagliptin 5mg tablets Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start